Stroke Fast Track Reduces Time Delay to Neuroimaging and Increases Use of Thrombolysis in an Academic Medical Center in Thailand

Journal of Neuroimaging

Volumn 22, Issue 1, 2012, Pages 53-57

  Ratanakorn, Disya ^a   Keandoungchun, Jesada ^a   Sittichanbuncha, Yuwares ^a   Laothamatas, Jiraporn ^a,b   Tegeler, Charles H ^c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Academic medical center; Stroke fast track; Thailand; Thrombolysis; Time to neuroimaging

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PATIENT CARE; STROKE; STROKE PATIENT; THAILAND; TRANSIENT ISCHEMIC ATTACK; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; MALE; MECHANICAL THROMBOLYSIS; MIDDLE AGED; NEUROIMAGING; STROKE; THAILAND; TIME MANAGEMENT; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; WAITING LISTS; YOUNG ADULT;

EID: 84855917258     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2010.00555.x     Document Type: Article

References (15)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 1995;333:1581-1587.
2. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
3. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke results of the MERCI trial. Stroke 2005;36:1432-1440.
4. Hacke W, Kaste M, Bluhmki E, et al. for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Eng J Med 2008;359:1317-1329.
5. Marler J, Jones P, Emr M, eds. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. Arlington, VA : National Institute of Neurological Disorders and Stroke, 1997.
6. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial.TOAST: trial of org 10172 in acute stroke treatment. Stroke 1993;24:35-41.
7. Chapman KM, Woolfenden AR, Graeb D, et al. Intravenous tissue plasminogen activator for acute ischemic stroke. A Canadian hospital's experience. Stroke 2000;31:2920-2924.
8. Acute Stroke Care in the US. Results from 4 Pilot Prototypes of the Paul Coverdell National Acute Stroke Registry: the Paul Coverdell Prototype Registries Writing Group. Stroke 2005;36:1232-1240.
9. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998;29:18-22.
10. Reed SD, Cramer SC, Blough DK, et al. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832-1840.
11. Grotta JC, Burgin WC, El-Mitwalli A, et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke Houston experience 1996 to 2000. Arch Neurol 2001;58:2009-2013.
12. Sharma VJ, Tsivgoulis G, Tan JH, et al. Feasibility and safety of intravenous thrombolysis in multiethnic Asian stroke patients in singapore. J Stroke Cerebrovasc Dis online June 2010:1-7.
13. Yamaguchi T, Mori E, Minematsu K, et al. Japan Alteplase Clinical Trial Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006;37:1810-1815.
14. Chao AC, Hsu HY, Chung CP, et al. Taiwan Thrombolytic Therapy for Acute Ischemic Stroke Study Group. Outcomes of thrombolytic therapy for acute ischemic stroke in Chinese patients. The Taiwan Thrombolytic Therapy for Acute Ischemic Stroke (TTT-AIS) Study. Stroke 2010;41:885-890.
15. Zhou XY, Wang SS, Collins ML, et al. Efficacy and safety of different doses of intravenous tissue plasminogen activator in Chinese patients with ischemic stroke. J Clin Neurosci 2010;17:988-992.